To test the hypothesis that the c-kit ligand plays an important role in the regulation of early events occurring during human hematopoiesis, we determined the effect of a recombinant form of c-kit ligand, termed mast cell growth factor (MGF), on the high-proliferative potential colony-forming cell (HPP-CFC) and the cell responsible for initiating long-term hematopoiesis in vitro (LTBMIC). MGF alone did not promote HPP-CFC colony formation by CD34' DR-CD15-marrow cells, but synergistically augmented the ability of a combination of granulocyte-monocyte colony-stimulating factor (GM-CSF) interleukin (IL)-3 and a recombinant GM-CSF/IL-3 fusion protein (FP) t o promote the formation of HPP-CFCderived colonies. MGF had a similarly profound effect on in vitro long-term hematopoiesis. Repeated additions of IL-3, GM-CSF, or FP alone t o CD34+ DR-CD15-marrow cells in a stromal cell-free culture system increased cell numbers lo3-fold by day 56 of long-term bone marrow culture (LTBMC), N VITRO assays for human colony-forming cells with I high-proliferative potential (HPP-CFC) and the cells responsible for initiating long-term marrow cultures in vitro (LTBMIC) have been used to examine the behavior of primitive human hematopoietic progenitor cells.l-lo Recently, both the human HPP-CFC and LTBMIC have been shown to be positive for the CD34 antigen but to lack detectable levels of the major histocompatibility class I1 locus HLA-DR. The phenotypic characterization of these primitive progenitors has allowed several groups to isolate marrow subpopulations enriched for their presence.8 " Long-term bone marrow culture (LTBMC) systems have been used to study the behavior of primitive mammalian hematopoietic cells.' ' These in vitro models have aided the study of hematopoietic stem cell proliferation and differentiation under conditions where close range interaction with marrow stromal elements is required. As originally described, LTBMC systems were dependent on the establishment of an adherent cell layer composed primarily of marrow stromal cells." Our laboratory has developed a modified LTBMC system independent of an established stromal cell layer? This stromal cell-free culture system is initiated with enriched populations of precursors of human marrow progenitor cells, which are then supplemented while combinations of MGF with IL-3 or FP yielded 10' -and 105-fold expansion of cell numbers. Expansion of the number of assayable colony-forming unit-granulocyte-monocyte (CFU-GM) generated during LTBMC was also markedly enhanced when MGF was added in combination with IL-3 or FP.
To test the hypothesis that the c-kit ligand plays an important role in the regulation of early events occurring during human hematopoiesis, we determined the effect of a recombinant form of c-kit ligand, termed mast cell growth factor (MGF), on the high-proliferative potential colony-forming cell (HPP-CFC) and the cell responsible for initiating long-term hematopoiesis in vitro (LTBMIC). MGF alone did not promote HPP-CFC colony formation by CD34' DR-CD15-marrow cells, but synergistically augmented the ability of a combination of granulocyte-monocyte colony-stimulating factor (GM-CSF) interleukin (IL)-3 and a recombinant GM-CSF/IL-3 fusion protein (FP) t o promote the formation of HPP-CFCderived colonies. MGF had a similarly profound effect on in vitro long-term hematopoiesis. Repeated additions of IL-3, GM-CSF, or FP alone t o CD34+ DR-CD15-marrow cells in a stromal cell-free culture system increased cell numbers lo3-fold by day 56 of long-term bone marrow culture (LTBMC), N VITRO assays for human colony-forming cells with I high-proliferative potential (HPP-CFC) and the cells responsible for initiating long-term marrow cultures in vitro (LTBMIC) have been used to examine the behavior of primitive human hematopoietic progenitor cells.l-lo Recently, both the human HPP-CFC and LTBMIC have been shown to be positive for the CD34 antigen but to lack detectable levels of the major histocompatibility class I1 locus HLA-DR. The phenotypic characterization of these primitive progenitors has allowed several groups to isolate marrow subpopulations enriched for their presence.8 " Long-term bone marrow culture (LTBMC) systems have been used to study the behavior of primitive mammalian hematopoietic cells. ' ' These in vitro models have aided the study of hematopoietic stem cell proliferation and differentiation under conditions where close range interaction with marrow stromal elements is required. As originally described, LTBMC systems were dependent on the establishment of an adherent cell layer composed primarily of marrow stromal cells." Our laboratory has developed a modified LTBMC system independent of an established stromal cell layer? This stromal cell-free culture system is initiated with enriched populations of precursors of human marrow progenitor cells, which are then supplemented while combinations of MGF with IL-3 or FP yielded 10' -and 105-fold expansion of cell numbers. Expansion of the number of assayable colony-forming unit-granulocyte-monocyte (CFU-GM) generated during LTBMC was also markedly enhanced when MGF was added in combination with IL-3 or FP. In addition, MGF, IL-3, and FP individually led to a twofold t o threefold increase in HPP-CFC numbers after 14 t o 21 days of LTBMC. Furthermore, the effects of these cytokines on HPP-CFC expansion during LTBMC were additive. Throughout the LTBMC, cells receiving MGF possessed a higher cloning efficiency than those receiving IL-3, GM-CSF, or FP alone. These data indicate that the c-kit ligand synergistically interacts with a number of cytokines t o directly augment the proliferative capacity of primitive human hematopoietic progenitor cells. o 1992 by The American Society of Hematology.
repeatedly throughout the duration of the LTBMC with individual cytokines or cytokine combinatiom8
Soluble forms of the ligand for c-kit have now been demonstrated by several groups to augment the proliferation of both myeloid and lymphoid hematopoietic progenitor cells.16-20 These molecules exhibit potent synergistic action in conjunction with other colony-stimulating factors, resulting in increased colony number and size.'6-20 The c-kit ligand has been variously referred to as mast cell growth factor (MGF), stem cell factor (SCF), kit ligand (KL), or steel locus factor (SLF) by various The c-kit ligand likely plays a major physiologic role in stem cell development in that a defect in its production leads to marrow failure in Because one of the sources of c-kit ligand is marrow stromal cells, we have hypothesized that it is a locally acting stromal cell factor that plays an important role in sustaining human stem cell development29.30 and therefore significantly influences the proliferation of both the HPP-CFC and LTBMIC.
Combinations of cytokines have been found to be most effective in promoting long-term hematopoiesis.' The delivery of a cytokine combination has previously been accomplished by the simultaneous addition of several individual cytokines to a culture sy~tem.~' Recently, a novel means of delivering such a cytokine combination has been developed. Williams et a1 created a granulocyte-monocyte colonystimulating factor (GM-CSF)/interleukin (1L)-3 fusion protein (FP) by constructing a plasmid in which the coding regions of human GM-CSF and IL-3 cDNAs were connected by a synthetic linker sequence.32 Since both GM-CSF and IL-3 possess multicolony-stimulating activities affecting the proliferation of several hematopoietic lineages:' the FP was used to examine the possibility that this cytokine combination plays an important role in the regulation of early events occurring during human hematopoiesis.
We have used fractions of human marrow cells previously shown to be enriched for the LTBMIC and HPP-CFC8 to evaluate the effects of soluble c-kit ligand alone and in combination with other cytokines on in vitro hematopoiesis. Our findings indicate that c-kit ligand has a profound effect on the proliferative capacity of both of these classes of primitive hematopoietic progenitor cells.
MATERIALS AND METHODS

Cell separation techniques.
Bone marrow samples were aspirated from the posterior iliac crest of normal volunteers after informed consent was obtained according to the guidelines established by the Human Investigation Committee of the Indiana University School of Medicine. Low-density mononuclear cells (LDBM) were isolated by density centrifugation of heparinized marrow layered over Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) at 50% for 25 minutes. LDBM cells were suspended in phosphate-buffered saline (PBS), pH 7.4, containing 5% fetal bovine serum (FBS), 0.01% EDTA wt/vol, and 1.0 g/L D-glucose, and injected into a Beckman counterflow centrifugal elutriation system at 10°C at a rotor speed of 1,950 rpm using a JA-17 rotor and standard separation chamber (Beckman Instruments, Palo Alto, CA). A fraction of the LDBM obtained at a flow rate of 12 to 14 mL/min was collected as previously described."
Elutriated marrow cells were sorted by previously published methods8 Briefly, cells were first incubated with mouse monoclonal anti-HPCA-1 (CD34) (IgG,, Becton Dickinson Immunocytometry Systems, San Jose, CA), washed, and stained with Texas red-conjugated, subclass-specific, goat anti-mouse IgG,, (Southern Biotechnology, Birmingham, AL). Unbound active sites were next blocked by incubation with mouse serum. Cells were finally stained with a combination of phycoerythrin-conjugated mouse anti-HLA-DR and fluorescein isothiocyanate (F1TC)-conjugated mouse anti-CD15 (Becton Dickinson Immunocytometry Systems). Controls consisted of the corresponding isotype-matched, nonspecific myeloma proteins used in parallel with the staining monoclonal antibodies. Cells were stained at a concentration of 2 x 107/mL and washed after each step in 1% bovine serum albumin (BSA) in PBS. In addition, a multicolor staining protocol previously described by Srour et al was used to allow simultaneous use of phycoerythrin-HLA-DR, Texas red-CD34, allophycocyanin-CD15, and rhodamine 123 (R123) to permit isolation of subpopulations of CD34+ DR-CD15-marrow cells based on rhodamine fluorescence."
Immediately after staining, cells were sorted on a Coulter Epics 753 dual-laser flow cytometer (Coulter Electronics, Hialeah, FL). Texas red was excited by 590 nm light emitted from a rhodamine 6-G dye laser. FITC and phycoerythrin were excited using the 488-nm wavelength from a dedicated 6-W argon laser. Cells were first gated on forward-angle light scatter and positive Texas red fluorescence. Sorting windows were next established for the absence of positive phycoerythrin and FITC signals to obtain the CD34' DR-CD15-cell population. In those experiments using rhodamine staining, sorting windows were established to divide CD34' DR-CD15-cells into R123d"" and R123br8h' subpopulations using previously published flow cytometer settings." Positivity for each fluorochrome was defined as fluorescence greater than 99% of the appropriate control. Cells were maintained at 4°C throughout the staining and cell sorting procedures.
Recombinant IL-3 (specific activity, 3. 
Long-term suspension cultures.
10' CD34+ DR-CD15-cells in 1 mL Iscove's modified Dulbecco's medium (IMDM) with 10% FBS and incubated at 37°C in 100% humidified 5% CO, in air.8 At initiation, and every 48 hours thereafter, cultures received no exogenous cytokine (1% BSA/ PBS), 500 pg/mL IL-3, 250 pg/mL GM-CSF, 10 ng/mL FP, 50 ng/mL murine or 10 ng/mL human MGF, or combinations thereof. At 7-day intervals, cultures were demidepopulated after agitation by replacement of one half the culture volume with fresh medium and cytokines. Cells in the harvested medium were counted, assayed for CFU-granulocyte-monocyte (CFU-GM), burst-forming unit-erythroid (BFU-E), and HPP-CFC, and transferred to slides for morphological examination.' To maintain a cell concentration less than 2 X 10'/mL at all times, it became necessary to demidepopulate cultures receiving both MGF and FP at intervals more frequent than weekly during the first 6 weeks of culture. In these cultures, 48-hour demidepopulations were common in the second through fourth week due to rapid growth.
Cells were suspended in plastic 35-mm tissue culture dishes containing 1 mL 30% FBS, 5 x lo-' mol/L 2-mercaptoethanol, 50 U/mL GM-CSF or as indicated, and 1.1% methylcellulose in IMDM. Cultures were incubated at 37°C in 100% humidified 5% CO, in air. After 14 days, CFU-GM colonies and BFU-E were enumerated in situ using an inverted microscope and standard criteria for their identification.'"," HPP-CFC were scored after 28 days in culture. The human HPP-CFC is a large ( > O S mm and frequently up to 2 to 3 mm in diameter), dense, late-appearing colony, composed primarily of granulocytes and a lesser number of monocytes, with cell numbers frequently exceeding 50,000.9 I" Statistical analysis. The results expressed as the mean f SEM were obtained from duplicate or quadruplicate experiments performed on separate occasions. Statistical significance was determined using the Student's t test.
Hematopoietic progenitor cell assays.
RESULTS
The effects of MGF were initially assessed by determining its ability to support HPP-CFC-derived colony formation in vitro by CD34+ DR-CD15-marrow cells (Table l) . HPP-CFC colony formation was promoted to a limited degree by the addition of GM-CSF, GM-CSF/IL-3, and FP. While MGF alone did not possess this HPP-CFC stimulatory activity, MGF synergized with both GM-CSF/IL-3 and FP, leading to a 7-to 12-fold increase in HPP-CFC-derived colony formation (Table 1) over that observed with FP or GM-CSF/IL-3 alone. The MGF/GM-CSF/IL-3 and MGF/FP combinations were equivalent in their ability to promote HPP-CFC-derived colonies (P < .OS).
To determine the effect of MGF on the cells responsible for long-term hematopoiesis, CD34' DR-CD15-marrow cells were seeded at a concentration of 5 x lo3 cells/mL in a stromal cell-free liquid culture system to which cytokines were added at 48-hour intervals. Table 2 illustrates the total hematopoietic cellular expansion of these cultures over the 10-week culture period. Low numbers of viable cells persisted for only 2 weeks in cultures receiving no exogenous cytokines. IL-3, GM-CSF, a combination of GM-CSF/IL-3, and FP each promoted a 100-to 1,000-fold expansion of cell number over the 10-week culture period. Repeated addition of MGF produced a similar level of cellular expansion. When combined with IL-3, MGF had a synergistic effect on cellular proliferation, resulting in a 2,000-fold increase in cell number by 8 weeks. The most dramatic cellular expansion was observed in cultures receiving a combination of MGF and FP, with a 10,000-to 100,000-fold increase in cell numbers occurring over the period of incubation. Table 3 shows the effect of MGF on the cellular composition of the LTBMCs during the initial month of culture. Unlike IL-3 or FP, which led to the terminal differentiation of myeloid cells after 14 days of observation, LTBMCs containing MGF alone or in combination with FP or IL-3 contained substantial numbers of hematopoietic blasts after 2 weeks in culture. Each of the LTBMCs examined after 4 weeks of incubation contained primarily terminally differentiated cellular elements (Table 3) . At no time throughout the 10-week culture period was any adherent cell population or stromal layer established.
The presence of assayable CFU-GM in these LTBMCs was also determined. CFU-GM were present in the LTBMCs to which no exogenous cytokines were added for only 1 week ( Table 4) . Repeated additions of IL-3, GM-CSF, GM-CSF/IL-3, and FP led to the production of assayable progenitor cells for 6 to 8 weeks, resulting in cumulative increases in CFU-GM several-fold greater than that present in the initial cellular innoculum ( -150). Repeated additions of MGF did not lead to an increased interval during which hematopoiesis might be sustained, but did result in a 3.5-to 12.2-fold increase in the cumulative production of CFU-GM when compared with the input population. The addition of MGF to either IL-3 or FP resulted in a remarkable synergistic augmentation of the numbers of assayable CFU-GM during the period of LTBMC (Table Long-term erythropoiesis was entirely dependent on the continued addition of exogenous cytokines (Table 5) . BFU-E remained assayable in the LTBMC following repeated additions of IL-3, GM-CSF, or FP for 1 to 4 weeks. Cultures receiving repeated additions of MGF alone generated BFU-E for 1 to 2 weeks. Addition of MGF to IL-3-or FP-supplemented LTBMC resulted in a synergistic increase in the production of BFU-E when compared to LTBMC supplemented with either IL-3 or FP alone, especially at the end of the first week of culture.
Long-term suspension cultures were assayed for HPP-CFC-derived colonies at initiation and after 14 to 28 days of 4). Total cells = cells/mL culture/(%)", where n = number of previous demidepopulations. Cultures were seeded at 5 x lo3 cells/mL.
Abbreviation: ND, not determined. "500 pg/mL recombinant human IL-3 was added every 48 hours; specific activity, 3.5 x 108CFU/mg protein. t250 pg/mL recombinant human GM-CSF was added every48 hours; specific activity, 2 x 108CFU/mg protein.
$10 ng/mL recombinant human FP was added every48 hours; specific activity, 1 to 2 x lo9 CFU/mg protein.
050 ng/mL recombinant murine MGF was added every48 hours; specific activity, 106CFU/mg protein.
For personal use only. on April 16, 2017. by guest www.bloodjournal.org From culture (Table 6 ). LTBMCs of CD34' DR-CD15-cells were capable of producing HPP-CFC for 21 days. Repeated additions of either recombinant MGF, IL-3, or FP were effective in expanding the number of HPP-CFC during LTBMC of CD34' DR-CD15-cells (Table 6 ). In fact, the action of MGF on HPP-CFC expansion in combination with IL-3 or FP appeared to be additive. When the CD34' DR-CD15-cells were further fractionated based on R123 fluorescence, the overwhelming majority of HPP-CFC were found to be R123dU", rather than R123b'igh' ( Table 6) . LTBMCs of these subpopulations of CD34' DR-CD15-cells to which MGF and FP were added every 48 hours Total CFU-GM = CFU-GM/mL culture/(%)", where n = number of previous demidepopulations. Cultures were seeded at 5 x lo3 cells/mL. CFU-GM/B x lo3 cells in initial population: donor 1, 150; donor 2, 227; donor 3, 144. Colonies grown in methylcellulose containing 500 pg/mL GM-CSF and 1 U human urinary erythropoietin and enumerated after 14 days. Donors 1 and 2 correspond to those in Tables 2 and 5. *500 pg/mL recombinant human IL-3 was added every 48 hours; specific activity, 3.5 x 108CFU/mg protein. t250 pg/mL recombinant human GM-CSF was added every 48 hours; specific activity, 2 x 106CFU/mg protein.
§50 ng/mL recombinant murine MGF was added every 48 hours; specific activity, lo6 CFU/mg protein.
For personal use only. on April 16, 2017. by guest www.bloodjournal.org From Colonies grown in methylcellulose containing 500 pg/mL GM-CSF and 1 U human recombinant erythropoietin and enumerated at 12 days. Donors 1 and 2 correspond to those in Tables 2 and 4. '500 pg/mL recombinant human IL-3 added every 48 hours; specific activity, 3.5 x lo8 CFU/mg protein.
t250 pg/mL recombinant human GM-CSF added every 48 hours; specific activity, 2 x 108CFU/mg protein.
*10 ng/mL recombinant human FP added every 48 hours; specific activity, 1 to 2 x lo8 CFU/mg protein.
950 ng/mL recombinant murine MGF added every 48 hours; specific activity, 10' CFU/mg protein.
showed that the R123*"" population was capable of a 2.4-fold increase of HPP-CFC numbers by day 21 of LTBMC. In addition, while the peak of HPP-CFC expansion by CD34' DR-CD15-cells occurred on day 14 of LTBMC, that of CD34' DR-CD15-R123d"" cells was delayed until day 21 of long-term culture.
To further examine the effect of MGF on progenitor cell expansion, the cloning efficiencies of the cells obtained during LTBMC were determined. In the presence of each of the cytokines alone or cytokine combinations, the cloning efficiency progressively declined during the period of LT-BMC. This decrease in cloning efficiency was most dramatic in those cultures supplemented with cytokines that had the greatest effect on proliferation, FP, IL-3, GM-CSF, and GM-CSF/IL-3. Cells from LTBMC repeatedly supplemented with MGF consistently had the highest cloning efficiency ( Table 7) . Addition of MGF to LTBMC receiving either FP or IL-3 led to higher cloning efficiencies than in cultures receiving FP or IL-3 alone.
DISCUSSION
Recently, several laboratories8-'6 have isolated cell populations from normal human bone marrow which have the capacity to undergo self-renewal and differentiation, two biological functions characteristic of stem cells. The human CFU-B1, HPP-CFC, and the cell responsible for initiating long-term hematopoiesis in vitro (LTBMIC) each possess similar phenotypic properties and a number of biological behavior patterns associated with human stem cells.*-16 A variety of in vitro assays have been used to determine the cytokine requirements of these primitive progenitor cell^.^^'^^^^ Such studies have indicated that multiple cytokines can affect their proliferation by acting either directly on these cellular targets or indirectly by causing accessory cells to secondarily elaborate additional cytokine~.",~~-~~ Our laboratory has used subpopulations of human marrow enriched for these various primitive hematopoietic progenitor cells to identify cytokines that directly affect their development either independently or via synergistic interactions.*
The cellular events that lead to blood cell production are influenced by multiple c y t~k i n e s .~~ Many of these cytokines are produced by marrow stromal cells or by cells that traffic through the marrow compartment.""38 Stromal cells likely influence hematopoietic stem cell development by elaborating a number of cytokines, including c-kit ligand.21-Z6.2Y~30 Several groups have now shown that the c-kit ligand alone has little biological activity against either rodent or human progenitor cells, but acts synergistically with several other cytokines in promoting their proliferation.16.'*~20 Such studies suggest that c-kit ligand acts directly on primitive hematopoietic progenitor cells.'6~'*~20
In the present studies, the effect of c-kit ligand on early events occurring during hematopoiesis was further examined. A system previously developed by our laboratory in which long-term cultures of highly enriched precursors of hematopoietic progenitor cells are repeatedly supplemented with cytokines was used for these studies.' Hematopoiesis is routinely sustained in this system for 6 to 10 weeks and is dependent on the continued addition of cytokines. No particular cytokine or cytokine combination was capable of prolonging the duration of LTBMC to a greater extent than the other, a parameter that might be used as a measure of stem cell self-renewal. While MGF alone was capable of sustaining long-term cellular proliferation, its actions were most dramatic in synergizing with IL-3 or FP. MGF enjoyed a profound synergistic effect with either FP or IL-3 in promoting expansion of the number of assayable CFU-GM; the most pronounced effect was again seen with MGFIFP. This enhancement by MGF of the response of hematopoietic cells to other growth factors responsible for cellular proliferation has been observed by other groups.16~,20.30 The cloning efficiency of the cells produced during the period of LTBMC demonstrated that although MGF had a limited effect on cellular proliferation, it enhanced in vitro progenitor cell survival. The decrease in cloning efficiency on LTBMCs receiving MGF was far slower than that observed with other cytokines. A higher percentage of blast cells was observed in cultures containing MGF alone or in combination with FP or IL-3 than in those sustained without MGF, again indicating that its presence favors the persistence of more primitive hematopoietic cell types.
This report provides further information on the phenotype and cytokine requirements of the human HPP-CFC.
For personal use only. on April 16, 2017. by guest www.bloodjournal.org From t500 pg/mL recombinant human IL-3 was added every48 hours; specific activity, 3.5 x lo* CFU/mg protein.
$50 ng/mL recombinant murine MGF was added every 48 hours; specific activity, lo6 CFU/mg protein. §10 ng/mL recombinant human MGF was added every 48 hours; specific activity, > lo5 CFU/mg protein.
710 ng/mL recombinant human FP was added every48 hours; specific activity, 1 to 2 x 10' CFU/mg protein.
11250 pg/mL recombinant human GM-CSF was added every 48 hours; specific activity, 2 x lo8 CFU/mg protein.
The human HPP-CFC is characterized by a high-proliferative potential, a prolonged culture period required for its resultant progeny to appear in vitro, and a relative resistance to 5-fluoroura~il.~~~ Murine HPP-CFC have been shown to generate progenitor cells of multiple hematopoietic lineages, as well as cells with in vitro marrow repopulating p~tential.~'.~' Such data suggest that the murine HPP-CFC represents a primitive cell population with properties Cloning efficiency = colonies enumerated/cells cultured x 100%. Cells at each time point were counted and cultured in methylcellulose containing 500 pg GM-CSF and 1 U human urinary erythropoietin or in fibrin clot containing 1 ng IL-3 and enumerated at 14 days. The total numbers of BFU-E, CFU-GM, HPP-CFC, CFU-granulocyte-erythrocyte-monocyte-megakaryocyte and CFU-megakaryocyte were determined to calculate the cloning efficiency. Each point represents the mean of two to four separate experiments. Mean cloning efficiency of initial (day 0) population: 4.54%.
*500 pg/mL recombinant human IL-3 was added every 48 hours; specific activity, 3.5 x I O * CFU/mg protein. t250 pg/mL recombinant human GM-CSF was added every 48 hours; specific activity, 2 x 108CFU/mg protein. $10 ng/mL recombinant human FP was added every 48 hours; specific activity, 1 to 2 x IO'CFU/mg protein.
150 ng/mL recombinant murine MGF was added every 48 hours; specific activity, lo6 CFU/mg protein.
For personal use only. on April 16, 2017. by guest www.bloodjournal.org From closely related to those of the true hematopoietic stem cell. It appears likely that the human HPP-CFC may similarly be useful as a means of quantitating primitive human progenitor cells that closely resemble hematopoietic stem cells. We have shown that subclasses of HPP-CFC can be obtained based on rhodamine fluorescence. The majority of human HPP-CFC reside within a R123dU" population of CD34' DR-CD15-marrow cells. A similar resolution of murine HPP-CFC based on rhodamine fluorescence has been recently reported,4' emphasizing the numerous similarities between human and murine HPP-CFC.
HPP-CFC colony formation has been previously shown to be dependent on the addition of cytokine combinat i o n~.~. ' "~~~'
Although GM-CSF alone was capable of stimulating the formation of HPP-CFC-derived colonies, its activity was less than that of either GM-CSF/IL-3 or FP. Remarkably, although MGF had minimal HPP-CFC colonystimulating activity, its addition had a synergistic effect on the ability of either GM-CSF/IL-3 or FP to promote HPP-CFC-derived colony formation. The HPP-CFC colonystimulating activity of MGF/GM-CSF/IL-3 and MGF/FP were virtually identical, indicating the similar action and activity of FP and GM-CSF/IL-3 for these purposes. This augmentation of HPP-CFC-derived colony formation suggests that at least three cytokines are required for the proliferation of HPP-CFC and that the c-kit ligand plays a critical role in this process by augmenting the effect of other cytokine combinations.
In an attempt to determine the effect of cytokines on expansion of stem cells or the cells responsible for marrow repopulation, their influence on HPP-CFC expansion in LTBMC was examined (Table 4) . Several cytokines, including MGF, IL-3, and FP, were capable of promoting HPP-CFC expansion after 2 to 3 weeks of LTBMC. In fact, the expansion of HPP-CFC numbers by MGF, IL-3, or FP appeared to be additive. Further characterization of the CD34' DR-CD15-cell fraction responsible for expansion of HPP-CFC number was performed. A R123dU'' form of this cell population was solely responsible for the resultant increase in HPP-CFC, whereas the R123b"gh' fraction was not capable of expanding the numbers of this primitive progenitor cell in response to MGF/FP. Several attempts to establish LTBMC using R123d"'' cells in our laboratory without the addition of MGF have failed, suggesting the dependence of this primitive cell type on such a cytokine.
These studies indicate that combinations of cytokines are required for the proliferation and differentiation of primitive human hematopoietic progenitor cells. The c-kit ligand appears to play a critical role in this expanding hematopoietic in vitro system. The remarkable synergistic interactions of the c-kit ligand with other cytokines, its ability to expand populations of undifferentiated hematopoietic and progenitor cell types, and its production by stromal cell elements suggest that this cytokine plays an important role in stem cell development within the marrow microenvironment. The therapeutic potential of MGF alone or in combination with FP appears promising. The in vitro HPP-CFC expansion reported here could be potentially useful in increasing the number of cells of marrow subpopulations responsible for engraftment following bone marrow transplantation. This remarkable expansion of hematopoietic progenitor cells raises the possibility that such cytokine combinations might eventually be used to produce cell products in vitro to be used for clinical transfusion in vivo.
